Former SEE intern Julia Joo thanks ISB
isbscience.org/news/2018/08/17/former-see-intern-thanks-isb/“I’m so grateful to ISB for giving me the opportunity to build the diverse lab-relevant skillset that made me a competitive candidate for research labs as an undergraduate,” said Julia Joo, who recently visited ISB and reflected on how her Systems Education Experiences internships shaped her academic and professional trajectory.
In 2013, Joo was a high school intern in ISB’s Hood Lab. In 2014, she came back for another internship, this time in the Huang Lab. Joo has since graduated from the University of Washington with a Biochemistry and Molecular, Cellular and Development Biology double major, and now she’s working at Seattle Children’s Research Institute Center for Immunity and Immunotherapies in the Miao Lab.
“With my experience in a cutting-edge research facility like ISB, I was able to be selective in choosing the lab I decided to join from those which offered me a position. I was incredibly fortunate to work on a project studying the sub-clonal variation of mutation spectra in glioblastoma tumors with Dr. Lawrence Loeb, the pioneer of the mutator phenotype hypothesis of cancer. I have ISB to thank for this experience, as I initially encountered Dr. Loeb’s work at the annual ISB Symposium in 2013, at which he was a keynote speaker.”
“Even years after my internship, I am constantly struck by the relevance of ISB’s mantra of using interdisciplinary methods to illuminate the complex networks of disease. The systems approach to biomedicine motivates me to learn new techniques across disciplines and deepen my understanding of coding languages so I can be better equipped to tackle the hurdle of heterogeneity of diseases between and within individual patients.”
“I am fascinated by the bridge between research and patient care, and thus am very excited to dive into the world of translational research as a Research Scientist in Dr. Carol Miao’s lab at the Seattle Children’s Research Institute. I’m thrilled to be designing immunotherapies for genetic diseases like hemophilia, knowing that my work will soon lead to real treatments that will help kids and adults alike to live safer and healthier lives.”
